Literature DB >> 15893240

[Pleural empyema in children: Montpellier's experience].

G Guyon1, H Allal, M Lalande, M Rodière.   

Abstract

OBJECTIVES AND
METHOD: To assess the management of pleural empyema in pediatric from a medical and surgical experience and a review of the literature. STUDY: Fifty-eight cases were reviewed from January 98 to December 2003. 62.6% have already received antibiotherapy. Forty-three percent of cases were less than three years old. Initial cultures identified Streptococcus pneumoniae in 39%, Streptococcus pyogenes in 5.6%, Mycoplasma pneumoniae and Staphylococcus aureus in only one case and were negative in 47%. A primitive or second-line thoracoscopy were used for drainage in two-third of the cases and mainly 6.95 days after admission. Located pleural empyema and major collected volume were the main indications for thoracoscopy. Three cases have been converted into open thoracotomy. One death occurred in an immunocompromised child. All patients were well at last follow-up. DISCUSSION: The frequency of parapneumonic empyema has increased since ten years. Progress of echography and endoscopy changed their management. Antibiotics have to be effective against pneumococcal infection. Chest tube drainage is necessary to assure the lung reexpansion in case of fibropurulent collection. The difficulty is to optimise the time of video-assisted thoracoscopy (VAT) using predictive criteria as loculations and pneumatoceles. VAT allowed the aspiration of pleural fluid and removing of fibrinous loculations. Moreover VAT achieved optimal adhesiolysis and the irrigation or decortication of the pleural cavity. VAT minimized duration of stay, of chest tube drainage and the indications of thoracotomy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15893240     DOI: 10.1016/s0929-693x(05)80013-2

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  1 in total

1.  Survey of childhood empyema in Asia: implications for detecting the unmeasured burden of culture-negative bacterial disease.

Authors:  Batmunkh Nyambat; Paul E Kilgore; Dong Eun Yong; Dang Duc Anh; Chen-Hsun Chiu; Xuzhuang Shen; Luis Jodar; Timothy L Ng; Hans L Bock; William P Hausdorff
Journal:  BMC Infect Dis       Date:  2008-07-11       Impact factor: 3.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.